Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Mira Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
MIRA
Nasdaq
8731
https://mirapharmaceuticals.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Mira Pharmaceuticals Inc
MIRA Making Strides Toward Breakthrough Treatment
- Apr 2nd, 2024 12:13 pm
Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission
- Apr 2nd, 2024 12:00 pm
MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor
- Mar 21st, 2024 3:04 pm
Is MIRA Pharmaceuticals (NASDAQ:MIRA) In A Good Position To Deliver On Growth Plans?
- Feb 6th, 2024 10:41 am
MIRA Pharmaceuticals Provides Corporate Update
- Feb 5th, 2024 1:30 pm
MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations
- Dec 4th, 2023 1:00 pm
MIRA Pharmaceuticals Announces Ketamir-2's Oral Bioavailability Predicted to be 80%
- Nov 29th, 2023 1:00 pm
MIRA Makes Great Deal for Potential Blockbuster
- Nov 27th, 2023 10:42 am
MIRA Pharmaceuticals To Host Shareholder Update Call on Tuesday, December 5, 2023 at 11:30 a.m. Eastern Time
- Nov 21st, 2023 3:42 pm
MIRA Pharmaceuticals Announces Paradigm-Shift in Cognitive Enhancement with MIRA1a
- Nov 21st, 2023 3:09 pm
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
- Nov 20th, 2023 1:00 pm
MIRA Continues to Pursue New Pain Relief
- Nov 14th, 2023 4:31 pm
MIRA: Developing Cannabis with Benefits and Without Side Effects
- Oct 26th, 2023 11:23 am
MIRA Pharmaceuticals Shows its Prescription Pill More Palatable and Potent Than Pot
- Sep 18th, 2023 12:30 pm
MIRA Pharmaceuticals and MZ Group Partner to Strengthen Investor Relations and Shareholder Communication Efforts
- Sep 5th, 2023 12:31 pm
MIRA Pharmaceuticals to Participate in 6th Annual Cannabinoid-Derived Drug Development Summit
- Aug 31st, 2023 12:31 pm
MIRA Pharmaceuticals to Host Virtual Roadshow Webinar on Monday, September 11, 2023 at 1:00 p.m. Eastern Time
- Aug 29th, 2023 3:39 pm
MIRA Pharmaceuticals, Inc. Discusses Potential of Revolutionary THC Analog Drug, MIRA1a, with The Stock Day Podcast
- Aug 9th, 2023 1:35 pm
MIRA Pharmaceuticals debuts on the Nasdaq with plans to revolutionize medicinal CBD and THC
- Aug 3rd, 2023 6:40 pm
Scroll